摘要
Abstract
Objective To investigate the clinical symptoms score and the influevce of serum factors of Qingrehuatan Prescription on AECOPD patients with Tanreyongfei Syndrome to analyze its efficacy. Methods 54 cases with AECOPD from July 2013 to March 2015 in the hospital were selected and divided into the experimental group (26 cases)and the control group (24 cases) according to the random number table method. All patients were given western medicine on a regular basis,and received the same nursing. Patients in the experimental group were added Qingrehuatan Prescription treatment. The two groups received 1 course for 10 d. Results After treat-ment,the clinical symptoms of all patients were mitigated,and the clinical symptom scores greatly improved (t=3. 50,P < 0. 05);the levels of serum IL-8,IL-4,IFN-gamma,and TNF-alpha were declined,and the decline in the experimental group was more obvious ( t=3. 67,3. 03,4. 51,3. 89,P < 0. 05). Conclusion Qingrehuatan Prescription in treating AECOPD patients with Tanreyongfei Syn-drome has obvious clinical efficacy,can significantly improve the patient ’ s physical condition and quality of life;its main mechanism is probably the Chinese native medicine ingredient suppressing the production and function of inflammatory markers in the body.关键词
慢性阻塞性肺疾病/痰热壅肺/临床疗效/血清因子Key words
chronic obstructive pulmonary disease/Tanreyongfei Syndrome/clinical efficacy/serum factor分类
医药卫生
